UT Southwestern aids national effort to recruit volunteers for medical research

November 11, 2009

DALLAS - Nov. 11, 2009 - A new national initiative involving UT Southwestern Medical Center will match volunteers who want to take part in medical research studies with the scientists who are leading those studies.

ResearchMatch is a national partnership that will provide a free meeting place - via the Web - where volunteers can be matched to a scientific research project, or clinical trial, for which they might qualify.

"For the people of North Texas, it offers access to clinical trials close to home at UT Southwestern and our partner institutions, as well as potential access to studies across the country," said Dr. Milton Packer, chairman of clinical sciences at UT Southwestern. "This initiative gives volunteers a tangible way to assist with medical research and make an impact on the future of their community and the world."

ResearchMatch, which can be accessed through UT Southwestern's Web site at www.utsouthwestern.edu/researchmatch, is funded by the National Institutes of Health through a grant program called the Clinical and Translational Science Awards (CTSA). It is maintained by Vanderbilt University in Tennessee and currently includes 52 U.S. institutions. UT Southwestern is one of four sites in Texas.

"Recruitment and retention of participants is a huge issue in clinical trials, especially for investigators working with rare diseases or complex protocols, for example where long-term commitment is critical," said Dr. Blair Holbein, director of the clinical investigator resource core at UT Southwestern and the institution's liaison with Vanderbilt. "ResearchMatch is an opportunity to cast a wider net into a deeper pool of potential subjects."

Because it is a research registry and contains personal information, numerous regulations are in place to protect the privacy of volunteers by strictly controlling access to the data.

"All the privacy issues have been addressed thoroughly, including rigorous provisions for protection of volunteers' personal information," said Dr. Suzanne Rivera, associate vice president for research services at UT Southwestern.

"An investigator, or anyone else for that matter, can't just pull private information out of this registry," she said. "There are gatekeeping mechanisms to make sure the information is used only for legitimate projects under careful oversight. Each research project in the database must first be approved by a review board from the investigator's home institution, which is a very thorough process designed to protect the rights and welfare of the volunteers."

Here is how ResearchMatch works:

Interested adult volunteers, parents or caregivers register on the ResearchMatch Web site (www.researchmatch.org) and indicate their interest in participating in research studies. Both healthy volunteers and those with specific medical conditions can sign up.

Beginning in January, researchers at UT Southwestern and other partnering institutions will submit information to the Web site's database about their studies and clinical trials and their need to recruit and enroll volunteers. Researchers across the country will then search the registry for potential volunteers that fit the criteria for their specific study - including any limits on geographic region -and will send a recruitment message to those people with more information about the study.

At that point, it's up to the volunteer to affirm whether the researcher can contact them directly. If agreed upon, the volunteer then becomes "visible" to the researcher, and the enrollment process continues directly between the researcher and the volunteer.
In 2007 UT Southwestern received a $34 million CTSA grant from the NIH to lead a wide-ranging collaborative initiative aimed at speeding the transfer of laboratory discoveries to new therapies that improve human health. That five-year grant established the North and Central Texas Clinical and Translational Science Initiative (NCTCTSI). The UT Southwestern-based collaboration includes several regional academic institutions, hospitals and community partners, who also will be able to participate in ResearchMatch.This news release is available on our World Wide Web home page at www.utsouthwestern.edu/home/news/index.html

To automatically receive news releases from UT Southwestern via e-mail, subscribe at www.utsouthwestern.edu/receivenews

Dr. Milton Packer -- www.utsouthwestern.edu/findfac/professional/0,2356,67302,00.html

UT Southwestern Medical Center

Related Clinical Trials Articles from Brightsurf:

Nearly 1 in 5 cancer patients less likely to enroll in clinical trials during pandemic
A significant portion of cancer patients may be less likely to enroll in a clinical trial due to the ongoing coronavirus pandemic.

COVID-19 clinical trials lack diversity
Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials.

Why we should trust registered clinical trials
In a time when we have to rely on clinical trials for COVID-19 drugs and vaccines, a new study brings good news about the credibility of registered clinical trials.

Inclusion of children in clinical trials of treatments for COVID-19
This Viewpoint discusses the exclusion of children from coronavirus disease 2019 (COVID-19) clinical trials and why that could harm treatment options for children.

Review evaluates how AI could boost the success of clinical trials
In a review publishing July 17, 2019 in the journal Trends in Pharmacological Sciences, researchers examined how artificial intelligence (AI) could affect drug development in the coming decade.

Kidney patients are neglected in clinical trials
The exclusion of patients with kidney diseases from clinical trials remains an unsolved problem that hinders optimal care of these patients.

Clinical trials beginning for possible preeclampsia treatment
For over 20 years, a team of researchers at Lund University has worked on developing a drug against preeclampsia -- a serious disorder which annually affects around 9 million pregnant women worldwide and is one of the main causes of death in both mothers and unborn babies.

Underenrollment in clinical trials: Patients not the problem
The authors of the study published this month in the Journal of Clinical Oncology investigated why many cancer clinical trials fail to enroll enough patients.

When designing clinical trials for huntington's disease, first ask the experts
Progress in understanding the genetic mutation responsible for Huntington's disease (HD) and at least some molecular underpinnings of the disease has resulted in a new era of clinical testing of potential treatments.

New ALS therapy in clinical trials
New research led by Washington University School of Medicine in St.

Read More: Clinical Trials News and Clinical Trials Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.